chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Muscular weakness, Pyrexia, Vaccination site pain
Clinical narrative: Extreme pain and swelling of left arm at injection site; Extreme pain and swelling of left arm at injection site; weakness in left arm; burning sensation on some parts of left arm and shoulder; chills; Fever; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 24-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:45 as DOSE 1, SINGLE for covid-19 immunization (24 year when vaccinated). The patient medical history was not reported. Concomitant medication included ibuprofen (IBUPROFEN) taken for an unspecified indication, from an unknown start date, calcium carbonate (TUMS [CALCIUM CARBONATE]) taken for an unspecified indication, from an unknown start date. The patient was not diagnosed with COVID-19 prior to the vaccination. On 01Mar2021 22:00, 8 hours after vaccination the patient experienced extreme pain and swelling of left arm at injection site, weakness in left arm, burning sensation on some parts of left arm and shoulder, fever and chills. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Extreme pain and swelling of left arm at injection site; Extreme pain and swelling of left arm at injection site; weakness in left arm; burning sensation on some parts of left arm and shoulder; chills; Fever; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 24-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 01Mar2021 14:45 as DOSE 1, SINGLE for covid-19 immunization (24 year when vaccinated). The patient medical history was not reported. Concomitant medication included ibuprofen (IBUPROFEN) taken for an unspecified indication, from an unknown start date, calcium carbonate (TUMS [CALCIUM CARBONATE]) taken for an unspecified indication, from an unknown start date. The patient was not diagnosed with COVID-19 prior to the vaccination. On 01Mar2021 22:00, 8 hours after vaccination the patient experienced extreme pain and swelling of left arm at injection site, weakness in left arm, burning sensation on some parts of left arm and shoulder, fever and chills. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dyspnoea, Erythema, Fatigue
Clinical narrative: Arm pain redness and swelling; Arm pain redness and swelling; Arm pain redness and swelling; fatigue; feeling unwell (fluish),; headache,; lymph nodes feeling swollen; no energy; air hunger; Nausea; muscle pain; joint pain; This is a spontaneous report from a contactable consumer. This non-pregnant 52 years old female consumer reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6200), dose 2 via an unspecified route of administration on 25Feb2021 at 11:00 am in left arm (at the age of 52-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Facility type was reported as other. Patient's medical history included Fibromyalgia, Ehlers Danlos, Headaches and Trigeminal Neuralgia static Tachycardia Syndrome, Osteoarthritis, Chronic Fatigue from an unspecified date to unknown if ongoing. There were known allergies to penicillin and aspirin. Historical vaccine included first dose of bnt162b2, lot number; EL9264, via an unspecified route of administration on 29Jan2021 at 07:00 pm in right arm for covid-19 immunisation. No other vaccines were given in four weeks. Concomitant medications (in two weeks) included clonazepam (CLONOPIN), valaciclovir hydrochloride (VALTREX), midodrine, paracetamol (TYLENOL) and omeprazole (PRILOSEC), all from an unspecified date to an unspecified date at unknown dosage for unknown indication. On 26Feb2021, patient experienced Arm pain redness and swelling, fatigue, feeling unwell (fluish), headache, lymph nodes feeling swollen, no energy, air hunger, nausea, muscle and joint pain. AE did not result in emergency room and physician's office visit. No treatment was given for the AE. Patient did not have covid prior vaccination and was not tested for covid post vaccination. The outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Malaise, Myalgia, Nausea
Clinical narrative: Arm pain redness and swelling; Arm pain redness and swelling; Arm pain redness and swelling; fatigue; feeling unwell (fluish),; headache,; lymph nodes feeling swollen; no energy; air hunger; Nausea; muscle pain; joint pain; This is a spontaneous report from a contactable consumer. This non-pregnant 52 years old female consumer reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6200), dose 2 via an unspecified route of administration on 25Feb2021 at 11:00 am in left arm (at the age of 52-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Facility type was reported as other. Patient's medical history included Fibromyalgia, Ehlers Danlos, Headaches and Trigeminal Neuralgia static Tachycardia Syndrome, Osteoarthritis, Chronic Fatigue from an unspecified date to unknown if ongoing. There were known allergies to penicillin and aspirin. Historical vaccine included first dose of bnt162b2, lot number; EL9264, via an unspecified route of administration on 29Jan2021 at 07:00 pm in right arm for covid-19 immunisation. No other vaccines were given in four weeks. Concomitant medications (in two weeks) included clonazepam (CLONOPIN), valaciclovir hydrochloride (VALTREX), midodrine, paracetamol (TYLENOL) and omeprazole (PRILOSEC), all from an unspecified date to an unspecified date at unknown dosage for unknown indication. On 26Feb2021, patient experienced Arm pain redness and swelling, fatigue, feeling unwell (fluish), headache, lymph nodes feeling swollen, no energy, air hunger, nausea, muscle and joint pain. AE did not result in emergency room and physician's office visit. No treatment was given for the AE. Patient did not have covid prior vaccination and was not tested for covid post vaccination. The outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Arm pain redness and swelling; Arm pain redness and swelling; Arm pain redness and swelling; fatigue; feeling unwell (fluish),; headache,; lymph nodes feeling swollen; no energy; air hunger; Nausea; muscle pain; joint pain; This is a spontaneous report from a contactable consumer. This non-pregnant 52 years old female consumer reported that she received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6200), dose 2 via an unspecified route of administration on 25Feb2021 at 11:00 am in left arm (at the age of 52-years-old) as DOSE 2, SINGLE for covid-19 immunisation. Facility type was reported as other. Patient's medical history included Fibromyalgia, Ehlers Danlos, Headaches and Trigeminal Neuralgia static Tachycardia Syndrome, Osteoarthritis, Chronic Fatigue from an unspecified date to unknown if ongoing. There were known allergies to penicillin and aspirin. Historical vaccine included first dose of bnt162b2, lot number; EL9264, via an unspecified route of administration on 29Jan2021 at 07:00 pm in right arm for covid-19 immunisation. No other vaccines were given in four weeks. Concomitant medications (in two weeks) included clonazepam (CLONOPIN), valaciclovir hydrochloride (VALTREX), midodrine, paracetamol (TYLENOL) and omeprazole (PRILOSEC), all from an unspecified date to an unspecified date at unknown dosage for unknown indication. On 26Feb2021, patient experienced Arm pain redness and swelling, fatigue, feeling unwell (fluish), headache, lymph nodes feeling swollen, no energy, air hunger, nausea, muscle and joint pain. AE did not result in emergency room and physician's office visit. No treatment was given for the AE. Patient did not have covid prior vaccination and was not tested for covid post vaccination. The outcome of events was not recovered.  No follow up attempts are possible. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Furuncle, Nail discolouration
Clinical narrative: Big toes on both feet became black at base of nail.; Toes became inflamed and hot; This is a spontaneous report from a contactable consumer (patient). An 80-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN6200, expiry date was not reported), via an unspecified route of administration, administered in arm left on 27Feb2021 at 15:45 (age at vaccination: 80-years-old) as dose 2, single for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient medical history was not reported and had no known allergies. The patient concomitant medications included levothyroxine sodium (LEVOTHYROXIN); phytosterols NOS (CHOLESTOFF ORIGINAL); vitamins; chondroitin sulfate, glucosamine hydrochloride, methylsulfonylmethane (TRIPLEFLEX). The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EN5318, expiry date was not reported) via an unspecified route of administration, administered on arm left (age at vaccination: 80-years-old) on 06Feb2021 at 15:00, as dose 1 single for covid-19 immunisation. On 04Mar2021 at 19:00, the patient had experienced black discoloration at base of nail of big toes on both feet and toes became inflamed and hot. Patient received no treatment for the events. The patient had not received any other vaccine within 4 weeks. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Fatigue, Headache
Clinical narrative: Terrible chills; Abdominal pain, across the whole part, just terrible abdominal pain; Joint pain; Muscle aches all over me, I never had that bad pain before and then all my muscles hurt; I had tiredness, very tired and it lasted for about a day; Headache; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6202, Expiration Date: Unknown), via an unspecified route of administration, administered in right arm on 27Feb2021 (at the age of 69 years) as dose number unknown, single for covid-19 immunisation. Medical history included ongoing blood pressure . Concomitant medications included some blood pressure medications. He does not have that information with him. Patient called to report some of the side effects for the Covid-19 vaccine Pfizer. On an unspecified date, the patient stated chills, terrible chills and abdominal pain, across the whole part, just terrible abdominal pain and then he had joint pain and muscle aches all over him. He never had that bad pain before and then all his muscles hurt. He had tiredness, very tired and it lasted for about a day. He just took a Motrin or Ibuprofen about, it was (sentence incomplete, pending for clarification), he got a little bit of a headache, the next day and he took Motrin and that was about fifteen hours later. Outcome of the events are unknown.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Terrible chills; Abdominal pain, across the whole part, just terrible abdominal pain; Joint pain; Muscle aches all over me, I never had that bad pain before and then all my muscles hurt; I had tiredness, very tired and it lasted for about a day; Headache; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EN6202, Expiration Date: Unknown), via an unspecified route of administration, administered in right arm on 27Feb2021 (at the age of 69 years) as dose number unknown, single for covid-19 immunisation. Medical history included ongoing blood pressure . Concomitant medications included some blood pressure medications. He does not have that information with him. Patient called to report some of the side effects for the Covid-19 vaccine Pfizer. On an unspecified date, the patient stated chills, terrible chills and abdominal pain, across the whole part, just terrible abdominal pain and then he had joint pain and muscle aches all over him. He never had that bad pain before and then all his muscles hurt. He had tiredness, very tired and it lasted for about a day. He just took a Motrin or Ibuprofen about, it was (sentence incomplete, pending for clarification), he got a little bit of a headache, the next day and he took Motrin and that was about fifteen hours later. Outcome of the events are unknown.  No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Neck mass, Peripheral swelling, Pruritus, Vaccination site pain
Clinical narrative: arm itching; arm swollen; lump near left neck; injection site sore; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 68-years-old female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EL9267, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 21Feb2021 18:39 as DOSE 1, SINGLE for covid-19 immunization (68 year when vaccinated). Medical history included ongoing hypertension and ongoing bone disorder. Concomitant medications included alendronate sodium (ALENDRONATE) taken for an unspecified indication, from an unknown start date, lisinopril (LISINOPRIL) taken for an unspecified indication, from an unknown start date. The patient previously took bactrim, flagyl 250, flu vaccine and experienced pyrexia. On 28Feb2021, the patient developed arm itching, arm swollen, lump near left neck and injection site sore. The patient was not taken to hospital or to any physician for the treatment. The patient rubbed alcohol for the treatment of the events. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Fatigue, Head discomfort
Clinical narrative: Dizzy; Had pink dots on my chest, my breast, my forearm, my upper arm both left and right; There were lots of dots; Really tired; my head is not clear; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL9267), via an unspecified route of administration on an unspecified date at the age of 78-year-old as dose 1 single for covid-19 immunisation. Medical history included o Mar2020 patient had mild case of Covid and  quarantined for 1 month, she had the major symptom was fatigue, really tired and did not wanted to do anything . Concomitant medications included metoprolol succinate (TOPROL XL) taken, once in the morning and once in the evening, levothyroxine sodium (SYNTHROID) taken once a day and  lovastatin (LOVASTATIN) taken, once a day  for an unspecified indication, start and stop date were not reported. On unspecified date, few minutes after the receiving vaccine she felt dizzy and it was not severe, so she did not say anything to, was in the waiting room where everybody was waiting for 15 minutes and did not mention it because it was not severe and then drove home which was an additional 15-20 minutes and decided to take a shower. Patient had pink dots on my chest, breast, forearm, upper arm both left and right. She also experienced being really tired and head was not clear. The patient wanted to know since the effects were not severe. So, basically, are there other people receiving the same reaction or if she go for dose two and Last March she had a case of Covid, so she also wants to know how that impact if the body had already made antibody protection, does that affect getting a vaccine. The patient did not receive any treatment in response to the events.  The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pain in extremity
Clinical narrative: Above the wrist, my arm is like reddish and it is hurts to the touch; Above the wrist, my arm is like reddish and it is hurts to the touch/Ache in the right arm above the wrist; I was really exhausted so I slept; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 81-years-old female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 25Feb2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization (81 year when vaccinated). The patient medical history and concomitant medications were not reported. On 27Feb2021, the patient reported that post 2 days of vaccination the patient felt really exhausted so she slept. On 02Mar2021, the patient reported that her right arm was like reddish and it hurt to the touch. The patient took aspirin to treat the events, also the patient had enough medicines for other stuff. The outcome of the event was reported as recovering, while for the events her right arm was like reddish and it hurt to the touch was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Feeling abnormal, Myalgia
Clinical narrative: Started feeling shivers; fever; muscle ache; just I wasn't comfortable; like my body is going asleep; Very tired/feels run down; Little nervous; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on 01Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 01Mar2021, the patient reported that until late night everything was going well, then the patient started feeling shivers, muscle ache, fever 100.3. The patient also reported that she wasn't comfortable, was feeling like body was going asleep, and very tired and feels runs down. On 01Mar2021, the patient had her body temperature checked and it was 100.3. The outcome of the events was reported as unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Nervousness, Pyrexia, Somnolence
Clinical narrative: Started feeling shivers; fever; muscle ache; just I wasn't comfortable; like my body is going asleep; Very tired/feels run down; Little nervous; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number unspecified, expiration date unspecified), via an unspecified route of administration on 01Mar2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 01Mar2021, the patient reported that until late night everything was going well, then the patient started feeling shivers, muscle ache, fever 100.3. The patient also reported that she wasn't comfortable, was feeling like body was going asleep, and very tired and feels runs down. On 01Mar2021, the patient had her body temperature checked and it was 100.3. The outcome of the events was reported as unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test
Clinical narrative: I cannot breathe; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date (reported as on 16th), as dose number unknown, single, for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date (reported as 28th), like almost two weeks later, the patient was laying watching TV and suddenly, could not breathe. So, the patient had to go to the emergency hospital. It was reported that, nobody tells the patient if that was a reaction of vaccine after 2 weeks. The reporter questioned if the event has something to do with the vaccine. The patient underwent lab tests and procedures which included COVID-19 test negative (further clarification unknown) on an unspecified date. The outcome for the event was unknown. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Pruritus, Sleep disorder
Clinical narrative: I started itching crazy enough I couldn't sleep/I woke up still itching/It woke me up about 4 Am itching again/I could not go back to sleep it was so bad; I started itching crazy enough I couldn't sleep/I woke up still itching/It woke me up about 4 Am itching again/I could not go back to sleep it was so bad; I started itching crazy enough I couldn't sleep/I woke up still itching/It woke me up about 4 Am itching again/I could not go back to sleep it was so bad; This is a spontaneous report from a contactable consumer or other non hcp. A 66-years-old female patient received bnt162b2 (BNT162B2) formulation solution for injection, dose 1 via an unspecified route of administration at arm left on 01Mar2021 13:30 (Lot Number: EN6202 expiry date was unknown) as a single dose for covid-19 immunisation. Medical history included depression from an unknown date and unknown if ongoing, pain from an unknown date and unknown if ongoing. Concomitant medication(s) included bupropion hydrochloride taken for depression from 2019 to an unspecified stop date; duloxetine hydrochloride taken for pain from 2019 to an unspecified stop date; gabapentin taken for pain from 2019 to an unspecified stop date. The patient experienced she started itching crazy enough she couldn't sleep woke up still itching it woke me up about 4 am itching again she could not go back to sleep it was so bad on 01Mar2021, Consumer stated she got the first vaccine yesterday about 1:30 and probably at midnight she started itching crazy enough she couldn't sleep. She doesn't have a real obvious rash that she could see it on my skin. So, she took a 100 mg of Benadryl and finally went to sleep. She woke up still itching. She had to take some more Benadryl. She just wonder is that a normal reaction. When paraphrased the above concern, Consumer stated Yes. It woke me up about 4 Am itching again. So, had to get up and take more and she could not go back to sleep it was so bad. Consumer stated No, there isn't a doctor who told me to get it. So, they give the prescriptions at the pharmacy. Dose: Consumer stated No, it just says Pfizer. Consumer stated Because she 66 and at risk. Treatment: Consumer stated, Benadryl 50 mg twice. No follow-up attempts are possible. No further information is expected. Outcome of the events was not recovered.    No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: Systemic: Patient had severe bloody nose about 30 minutes after-Medium, Additional Details: Patient received her 1st dose of covid vaccine and then sat and waited 15 minutes, then shopped in-store for around 10 min after, then walked to the bus stop across the street and started to have a fairly severe bloody nose. Asked if she wanted me to call the paramedics, and she did, but was not taken with them, was ok to go home. She stated that she does have chronic nose bleeds during times of stress, and had a stressful morning with her daughter at appointments.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Acidosis, Acute respiratory failure, Atrial fibrillation, Bacterial infection, Blood culture negative
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Cardio-respiratory arrest, Chest X-ray abnormal, Cough
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Echocardiogram, Echocardiogram normal, Ejection fraction
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram normal, Endotracheal intubation, Intensive care, Lung infiltration, Mechanical ventilation
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Prone position, Pulse absent, Pyrexia, Resuscitation
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Ultrasound Doppler normal, Ultrasound scan normal, Vaccine breakthrough infection
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count
Clinical narrative: Patient required hospitalization due to breakthrough infection. Patient received J&J vaccine on 08/11/21. Patient was hospitalized from 08/19/21 - 09/12/21. Below is copied from discharge (death) summary:    Patient is a 62 y.o. male with PMH significant for HLD, morbid obesity, DMII, schizophrenia, and anxiety/depression who presents for shortness of breath 2/2 to COVID. Initially admitted on 8/19/21. Patient had increasing O2 requirements with multiples desaturations on HFNC, and subsequently admitted on 8/31 for acute hypoxic respiratory failure/worsening O2 requirements 2/2 COVID PNA. Pt intubated on 8/31. Episodes of Paroxysmal A-fib, lopressor started and amiodarone started on 9/1. HDS during episodes. Bedside echo demonstrated reduced EF. Formal echo on 9/1 was normal LVEF 65%. Fever spiked  8/31 empiric abx (Vanc and Cefepime and flagyl) started. Blood, urine, and respiratory cultures ordered.  Initiated prone ventilation with improving oxygenation. Continue solumedrol, floloan, and statin. DVT ppx. No Toci given duration of illness. Afib with RVR but his cardiac function is wnl so this likely driven by his sepsis and hypoxia. Continue Amio. Strep/Staph bacteremia, however, may be contamination and unable to speciate staph so given his clinical picture, will treat and continue Cefepime. D/c Vanc. D/c Cefepime. Switched to Ancef given MSSA pneumonia. Repeat blood cultures negative. Strep viridans 1/2 blood cultures. Weaning Solumdrol. Tolerating prone ventilation. Procal remains negative but up trending WBC so will send fungal cultures. US lower extremity negative for DVT. US UE negative. Diuresing with Lasix 60 mg IV x2. Robitussin-codeine started for cough. Fevers persistent and WBC slowly downtrending.  D/c Diamox given mild worsening of acidosis. NPH 25 bid with SSI. CXR concerning for progression to fibrotic covid.  S/p Ancef for MSSA pneumonia. Progressive  Hemodynamic instability 9/11 requiring pressors with levophed and vasopressin. Repeat blood cultures 9/10, 1/2 with gram positive rods. Started on vanc/zosyn/caspofungin for broad coverage on 9/11. Called at 10:00PM for lost pulses. Pulse check without pulse. ACLS inititated as patient was full code at the time. Patient received 2x Epi/Bicarb, IVF bolus, and 3 rounds of CPR with PEA. At 3rd pulse check, patient with ROSC. Epi gtt initiated alongside Levo/Vaso/IVF. Pulse Ox with persisent desaturation depsite max FiO2/PEEP. Bedside US without signs of PNX or RV enlargement/strain. ECG without RV strain. CXR without signs of PNX; persistent b/l infiltrates consistent with active COVID. Called significant other, pt made DNR. Bicarb and epi gtt added. Pt's pulse lost again. Time of death 10:17.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Injection site erythema, Injection site pruritus, Injection site swelling, Pruritus
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Dizziness / Lightheadness-Mild
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Itch Generalized-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium, Systemic: Dizziness / Lightheadness-Mild
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Menstrual disorder
Clinical narrative: Menstrual change. My period is always on time and lasts 3/4 days. Period has been spotty Monday and Tuesday but wasn't supposed to start until Saturday which is highly unusual for me.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage/temperature.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage/temperature.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper storage/temperature.